drugset / Trial / NCT03472313
Assessment of the Biodistribution and Safety of [18F]MNI-958 in Healthy Subjects
NaSingle-groupOpen-labelOther
Summary
The overall goal of this protocol is to evaluate the biodistribution of \[18F\]MNI-958 also known as APN-0000455 or PM-PBB3, as a tau targeted radiopharmaceutical.
Timeline
- Start
- 2017-11-14
- Primary completion
- 2018-04-20
- Completion
- 2018-04-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | [18F]APN-1607 | Diagnostic / imaging agent | — | Other |
Indications
No indication recorded.